Pharma has kicked off the new year with its most expensive drug yet: a therapy to treat a rare form of blindness that will cost $850,000. The drug, called Luxturna, was originally rumored to potentially be the first million dollar drug, which has led Spark, the creators of the drug, to consider the exorbitant price a bargain:
"We wanted to balance the value and the affordability concerns with a responsible price that would ensure access to patients,"
said CEO Jeffrey Marrazzo, in an interview with The Associated Press.
Read AP's full report on Luxturna here.